Exgasmaster I'm not so sure they are trying to reinvent the wheel as they are treading very carefully through the initial stages of commercialization. Imho, some of this stems from an effort on their part to avoid further conflict with the FDA. It is imperative that use of the equipment remains well within the scope of the FDA approval. regards endo
Exa, please read my summary notes on the Needham conference Jan 12 , 2012. The 3 rd paragraph from the bottom ( on reimbursements) will help explain why this roll out is proceeding in the way it is.
Other factors to consider besides the ones already elucidated ad naseum by fellow members of this board, are the finalization of the manufacturing agreement in March after FDA approval in Nov. and raising of more funds; also bringing on board a marketing team shortly thereafter; and we are only in the 4th month of the roll out.
We all share your frustration. Let's see what the next CC reporting looks like. Respectfully, Sam